Vault-13

DEERFIELD MANAGEMENT COMPANY, L.P.

New York, NY · CIK 1009258 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2012 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 86
Parsippany, NJUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
AnalystNew York, NY 2 $140,000
Data EngineerNew York, NY 1 $210,000
Senior Director, Business IntelligenceNew York, NY 1 $195,000
Director, Business IntelligenceNew York, NY 1 $180,000
Market Research AssociateNew York, NY 1 $80,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$4.7bn reported value +4.4% vs Q1 2023
101positions
50.1%in top 10
18 new 20 added 10 reduced 23 sold out vs Q1 2023

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 19,991,024 $843.0m18.00% 18.00% UnchangedShares held: Q3 2022 19.3m, Q4 2022 20.0m, Q1 2023 20.0m, Q2 2023 20.0m
2 GLAUKOS CORP NOTE 2.750% 6/1 · principal GKOS 2.75 06.15.27 · principal GKOS 2.75 06.15.27 271,452,000 $412.7m8.81% 8.81% ReducedPrincipal held: Q3 2022 271.8m, Q4 2022 271.8m, Q1 2023 271.8m, Q2 2023 271.5m -300.0k -300,000 -0.1%
3 VIATRIS INC COM VTRS VTRS 17,703,484 $176.7m3.77% 3.77% AddedShares held: Q3 2022 10.7m, Q4 2022 10.0m, Q1 2023 16.9m, Q2 2023 17.7m +767.5k +767,487 4.5%
4 AMEDISYS INC COM AMED AMED 1,794,000 $164.0m3.50% 3.50% AddedShares held: Q3 2022 359.8k, Q4 2022 1.1m, Q1 2023 1.5m, Q2 2023 1.8m +310.8k +310,821 21.0%
5 NATERA INC NOTE 2.250% 5/0 · principal NTRA 2.25 05.01.27 · principal NTRA 2.25 05.01.27 101,042,000 $146.9m3.14% 3.14% UnchangedPrincipal held: Q3 2022 37.6m, Q4 2022 84.9m, Q1 2023 101.0m, Q2 2023 101.0m
6 ADAPTHEALTH CORP COMMON STOCK AHCO AHCO 11,094,914 $135.0m2.88% 2.88% AddedShares held: Q3 2022 8.2m, Q4 2022 7.6m, Q1 2023 10.6m, Q2 2023 11.1m +500.0k +500,000 4.7%
7 IONIS PHARMACEUTICALS INC NOTE 4/0 · principal IONS 0 04.01.26 · principal IONS 0 04.01.26 127,800,000 $121.0m2.58% 2.58% UnchangedPrincipal held: Q3 2022 127.8m, Q4 2022 127.8m, Q1 2023 127.8m, Q2 2023 127.8m
8 TABULA RASA HEALTHCARE INC NOTE 1.750% 2/1 · principal TRHC 1.75 02.15.26 · principal TRHC 1.75 02.15.26 144,516,000 $120.0m2.56% 2.56% UnchangedPrincipal held: Q3 2022 144.5m, Q4 2022 144.5m, Q1 2023 144.5m, Q2 2023 144.5m
9 BROOKDALE SR LIVING INC NOTE 2.000%10/1 · principal BKD 2 10.15.26 · principal BKD 2 10.15.26 145,955,000 $114.8m2.45% 2.45% UnchangedPrincipal held: Q3 2022 0, Q4 2022 146.0m, Q1 2023 146.0m, Q2 2023 146.0m
10 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,209,714 $114.1m2.44% 2.44% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.7m, Q2 2023 1.2m -535.0k -535,000 -30.7%
11 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 8,192,000 $110.1m2.35% 2.35% ReducedShares held: Q3 2022 4.9m, Q4 2022 5.9m, Q1 2023 10.4m, Q2 2023 8.2m -2.2m -2,163,099 -20.9%
12 ACCOLADE INC NOTE 0.500% 4/0 · principal ACCD 0.5 04.01.26 · principal ACCD 0.5 04.01.26 122,598,000 $102.1m2.18% 2.18% UnchangedPrincipal held: Q3 2022 105.0m, Q4 2022 105.0m, Q1 2023 122.6m, Q2 2023 122.6m
13 INSMED INC NOTE 1.750% 1/1 · principal INSM 1.75 01.15.25 · principal INSM 1.75 01.15.25 103,200,000 $98.2m2.10% 2.10% UnchangedPrincipal held: Q3 2022 75.0m, Q4 2022 102.7m, Q1 2023 103.2m, Q2 2023 103.2m
14 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 6,707,026 $94.4m2.02% 2.02% AddedShares held: Q3 2022 2.5m, Q4 2022 2.3m, Q1 2023 5.2m, Q2 2023 6.7m +1.5m +1,488,388 28.5%
15 INTERCEPT PHARMACEUTICALS IN NOTE 3.500% 2/1 · principal ICPT 3.5 02.15.26 · principal ICPT 3.5 02.15.26 98,354,000 $94.0m2.01% 2.01% UnchangedPrincipal held: Q3 2022 78.5m, Q4 2022 98.4m, Q1 2023 98.4m, Q2 2023 98.4m
16 CENTENE CORP DEL COM CNC CNC 1,349,000 $91.0m1.94% 1.94% AddedShares held: Q3 2022 464.0k, Q4 2022 565.0k, Q1 2023 1.1m, Q2 2023 1.3m +274.0k +274,000 25.5%
17 OWENS & MINOR INC NEW COM ACH ACH 4,745,000 $90.3m1.93% 1.93% AddedShares held: Q3 2022 0, Q4 2022 1.2m, Q1 2023 3.9m, Q2 2023 4.7m +877.5k +877,545 22.7%
18 MERUS N V COM MRUS MRUS 3,031,938 $79.8m1.70% 1.70% AddedShares held: Q3 2022 2.5m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 3.0m +651.5k +651,500 27.4%
19 ARS PHARMACEUTICALS INC COM SPRY SPRY 11,077,927 $74.2m1.58% 1.58% UnchangedShares held: Q3 2022 0, Q4 2022 11.1m, Q1 2023 11.1m, Q2 2023 11.1m
20 GUARDANT HEALTH INC NOTE 11/1 · principal GH 0 11.15.27 · principal GH 0 11.15.27 89,036,000 $63.9m1.36% 1.36% UnchangedPrincipal held: Q3 2022 89.0m, Q4 2022 89.0m, Q1 2023 89.0m, Q2 2023 89.0m
21 HILLEVAX INC COM COM 3,329,231 $57.2m1.22% 1.22% AddedShares held: Q3 2022 2.7m, Q4 2022 2.7m, Q1 2023 2.8m, Q2 2023 3.3m +495.5k +495,541 17.5%
22 ENHABIT INC COM EHAB EHAB 4,809,803 $55.3m1.18% 1.18% AddedShares held: Q3 2022 1.5m, Q4 2022 3.0m, Q1 2023 3.4m, Q2 2023 4.8m +1.4m +1,411,057 41.5%
23 NANOSTRING TECHNOLOGIES INC NOTE 2.625% 3/0 · principal NSTG 2.625 03.01.25 · principal NSTG 2.625 03.01.25 70,204,000 $54.8m1.17% 1.17% UnchangedPrincipal held: Q3 2022 57.6m, Q4 2022 70.2m, Q1 2023 70.2m, Q2 2023 70.2m
24 BROOKDALE SR LIVING INC COM BKD BKD 12,679,651 $53.5m1.14% 1.14% ReducedShares held: Q3 2022 8.7m, Q4 2022 12.7m, Q1 2023 16.4m, Q2 2023 12.7m -3.7m -3,726,396 -22.7%
25 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,268,628 $53.3m1.14% 1.14% AddedShares held: Q3 2022 1.7m, Q4 2022 1.7m, Q1 2023 1.7m, Q2 2023 2.3m +525.0k +525,000 30.1%
26 LARIMAR THERAPEUTICS INC COM LRMR LRMR 16,941,357 $53.0m1.13% 1.13% UnchangedShares held: Q3 2022 16.9m, Q4 2022 16.9m, Q1 2023 16.9m, Q2 2023 16.9m
27 CAREMAX INC COM CL A COM CL A 15,861,090 $49.3m1.05% 1.05% UnchangedShares held: Q3 2022 15.9m, Q4 2022 15.9m, Q1 2023 15.9m, Q2 2023 15.9m
28 REVOLUTION MEDICINES INC COM RVMD RVMD 1,751,496 $46.9m1.00% 1.00% AddedShares held: Q3 2022 2.9m, Q4 2022 891.6k, Q1 2023 829.7k, Q2 2023 1.8m +921.8k +921,759 111.1%
29 LIVONGO HEALTH INC NOTE 0.875% 6/0 · principal TDOC 0.875 06.01.25 · principal TDOC 0.875 06.01.25 50,000,000 $45.2m0.96% 0.96% UnchangedPrincipal held: Q3 2022 50.0m, Q4 2022 50.0m, Q1 2023 50.0m, Q2 2023 50.0m
30 GUARDANT HEALTH INC COM GH GH 1,253,999 $44.9m0.96% 0.96% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 779.0k, Q2 2023 1.3m +475.0k +475,000 61.0%
31 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 1,579,349 $41.4m0.88% 0.88% UnchangedShares held: Q3 2022 817.0k, Q4 2022 1.0m, Q1 2023 1.6m, Q2 2023 1.6m
32 COGENT BIOSCIENCES INC COM COGT COGT 3,366,345 $39.9m0.85% 0.85% AddedShares held: Q3 2022 3.0m, Q4 2022 3.0m, Q1 2023 3.0m, Q2 2023 3.4m +400.0k +400,000 13.5%
33 SILK RD MED INC COM SILK SILK 1,132,229 $36.8m0.79% 0.79% ReducedShares held: Q3 2022 2.5m, Q4 2022 1.4m, Q1 2023 1.7m, Q2 2023 1.1m -593.4k -593,411 -34.4%
34 KURA ONCOLOGY INC COM KURA KURA 3,238,000 $34.3m0.73% 0.73% AddedShares held: Q3 2022 2.2m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 3.2m +855.0k +855,000 35.9%
35 PTC THERAPEUTICS INC NOTE 1.500% 9/1 · principal PTCT 1.5 09.15.26 · principal PTCT 1.5 09.15.26 32,000,000 $33.0m0.70% 0.70% UnchangedPrincipal held: Q3 2022 32.0m, Q4 2022 32.0m, Q1 2023 32.0m, Q2 2023 32.0m
36 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 3,933,137 $30.5m0.65% 0.65% UnchangedShares held: Q3 2022 3.9m, Q4 2022 3.9m, Q1 2023 3.9m, Q2 2023 3.9m
37 CABALETTA BIO INC COM CABA CABA 2,340,118 $30.2m0.64% 0.64% AddedShares held: Q3 2022 464.3k, Q4 2022 464.3k, Q1 2023 464.3k, Q2 2023 2.3m +1.9m +1,875,866 404.1%
38 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 2,535,723 $30.1m0.64% 0.64% UnchangedShares held: Q3 2022 0, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
39 DOCGO INC COM DCGO DCGO 3,059,000 $28.7m0.61% 0.61% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.1m, Q2 2023 3.1m
40 HEALTH CATALYST INC NOTE 2.500% 4/1 · principal HCAT 2.5 04.15.25 · principal HCAT 2.5 04.15.25 30,000,000 $28.6m0.61% 0.61% UnchangedPrincipal held: Q3 2022 30.0m, Q4 2022 30.0m, Q1 2023 30.0m, Q2 2023 30.0m
41 APELLIS PHARMACEUTICALS INC COM APLS APLS 313,289 $28.5m0.61% 0.61% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 313.3k
42 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 627,813 $26.1m0.56% 0.56% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 375.0k, Q2 2023 627.8k +252.8k +252,813 67.4%
43 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 2,077,893 $23.0m0.49% 0.49% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.1m
44 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 1,050,198 $22.7m0.48% 0.48% ReducedShares held: Q3 2022 0, Q4 2022 2.7m, Q1 2023 2.0m, Q2 2023 1.1m -934.1k -934,135 -47.1%
45 REVANCE THERAPEUTICS INC COM RVNC RVNC 870,000 $22.0m0.47% 0.47% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 870.0k
46 XERIS BIOPHARMA HOLDINGS INC NOTE 5.000% 7/1 · principal XERS 5 07.15.25 · principal XERS 5 07.15.25 18,000,000 $21.4m0.46% 0.46% UnchangedPrincipal held: Q3 2022 18.0m, Q4 2022 18.0m, Q1 2023 18.0m, Q2 2023 18.0m
47 ALPHATEC HLDGS INC COM NEW ATEC ATEC 1,189,648 $21.4m0.46% 0.46% AddedShares held: Q3 2022 2.5m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.2m +142.9k +142,857 13.7%
48 VENTYX BIOSCIENCES INC COM VTYX VTYX 617,000 $20.2m0.43% 0.43% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 617.0k, Q2 2023 617.0k
49 VIGIL NEUROSCIENCE INC COM VIGL VIGL 2,052,010 $19.3m0.41% 0.41% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
50 DISC MEDICINE INC COM IRON IRON 430,000 $19.1m0.41% 0.41% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 430.0k
51 VIKING THERAPEUTICS INC COM VKTX VKTX 1,125,000 $18.2m0.39% 0.39% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.1m, Q2 2023 1.1m
52 DENALI THERAPEUTICS INC COM DNLI DNLI 594,989 $17.6m0.37% 0.37% UnchangedShares held: Q3 2022 0, Q4 2022 800.0k, Q1 2023 595.0k, Q2 2023 595.0k
53 TERNS PHARMACEUTICALS INC COM COM 1,898,743 $16.6m0.35% 0.35% ReducedShares held: Q3 2022 1.9m, Q4 2022 2.9m, Q1 2023 2.1m, Q2 2023 1.9m -160.7k -160,678 -7.8%
54 DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM CLASS A COM 1,600,000 $16.4m0.35% 0.35% UnchangedShares held: Q3 2022 1.6m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 1.6m
55 INVITAE CORP NOTE 2.000% 9/0 · principal NVTA 2 09.01.24 · principal NVTA 2 09.01.24 17,211,000 $15.3m0.33% 0.33% AddedPrincipal held: Q3 2022 206.9m, Q4 2022 241.9m, Q1 2023 15.7m, Q2 2023 17.2m +1.5m +1,500,000 9.6%
56 DAY ONE BIOPHARMACEUTICALS I COM COM 1,269,992 $15.2m0.32% 0.32% NewShares held: Q3 2022 1.0m, Q4 2022 964.0k, Q1 2023 0, Q2 2023 1.3m
57 MINERALYS THERAPEUTICS INC COM MLYS MLYS 837,000 $14.3m0.30% 0.30% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 729.0k, Q2 2023 837.0k +108.0k +107,979 14.8%
58 PULMONX CORP COM LUNG LUNG 1,064,285 $14.0m0.30% 0.30% ReducedShares held: Q3 2022 3.7m, Q4 2022 0, Q1 2023 2.4m, Q2 2023 1.1m -1.3m -1,338,419 -55.7%
59 INSMED INC COM PAR $.01 INSM INSM 658,546 $13.9m0.30% 0.30% UnchangedShares held: Q3 2022 960.5k, Q4 2022 664.1k, Q1 2023 658.5k, Q2 2023 658.5k
60 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,354,974 $13.7m0.29% 0.29% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.8m, Q2 2023 1.4m -395.0k -395,026 -22.6%
61 ACELYRIN INC COM COM 650,000 $13.6m0.29% 0.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 650.0k
62 FUSION PHARMACEUTICALS INC COM COM 2,823,000 $13.2m0.28% 0.28% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.8m, Q2 2023 2.8m
63 THESEUS PHARMACEUTICALS INC COM COM 1,400,352 $13.1m0.28% 0.28% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.4m
64 PRIME MEDICINE INC COM PRME PRME 885,314 $13.0m0.28% 0.28% UnchangedShares held: Q3 2022 0, Q4 2022 885.3k, Q1 2023 885.3k, Q2 2023 885.3k
65 ANAPTYSBIO INC COM ANAB ANAB 613,000 $12.5m0.27% 0.27% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.2m, Q1 2023 613.0k, Q2 2023 613.0k
66 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 650,000 $11.7m0.25% 0.25% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 650.0k
67 VERASTEM INC COM NEW VSTM VSTM 1,538,461 $11.4m0.24% 0.24% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.5m
68 AXONICS INC COM AXNX AXNX 225,000 $11.4m0.24% 0.24% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 225.0k
69 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 1,842,000 $10.6m0.23% 0.23% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.8m
70 NUVATION BIO INC COM CL A NUVB NUVB 5,854,860 $10.5m0.22% 0.22% UnchangedShares held: Q3 2022 245.4k, Q4 2022 5.9m, Q1 2023 5.9m, Q2 2023 5.9m
71 MERSANA THERAPEUTICS INC COM COM 2,885,400 $9.5m0.20% 0.20% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.9m
72 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 656,000 $9.4m0.20% 0.20% NewShares held: Q3 2022 2.4m, Q4 2022 0, Q1 2023 0, Q2 2023 656.0k
73 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,322,000 $9.3m0.20% 0.20% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.8m, Q2 2023 1.3m -1.4m -1,443,000 -52.2%
74 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 1,800,000 $9.1m0.19% 0.19% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.8m
75 GENEDX HOLDINGS CORP COM CL A WGS WGS 1,253,895 $7.5m0.16% 0.16% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
76 ALECTOR INC COM ALEC ALEC 1,055,192 $6.3m0.14% 0.14% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
77 NEOGENOMICS INC NOTE 1.250% 5/0 · principal NEO 1.25 05.01.25 · principal NEO 1.25 05.01.25 6,500,000 $6.1m0.13% 0.13% UnchangedPrincipal held: Q3 2022 6.5m, Q4 2022 6.5m, Q1 2023 6.5m, Q2 2023 6.5m
78 FOGHORN THERAPEUTICS INC COM FHTX FHTX 777,525 $5.5m0.12% 0.12% UnchangedShares held: Q3 2022 777.5k, Q4 2022 777.5k, Q1 2023 777.5k, Q2 2023 777.5k
79 SINGULAR GENOMICS SYSTEMS IN COM COM 6,450,871 $5.4m0.11% 0.11% UnchangedShares held: Q3 2022 7.1m, Q4 2022 6.5m, Q1 2023 6.5m, Q2 2023 6.5m
80 NYXOAH S A SHS NYXH NYXH 455,262 $3.6m0.08% 0.08% UnchangedShares held: Q3 2022 455.3k, Q4 2022 455.3k, Q1 2023 455.3k, Q2 2023 455.3k
81 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 869,565 $3.5m0.07% 0.07% UnchangedShares held: Q3 2022 0, Q4 2022 869.6k, Q1 2023 869.6k, Q2 2023 869.6k
82 ROIVANT SCIENCES LTD *W EXP 09/30/202 *W EXP 09/30/202 1,000,000 $2.5m0.05% 0.05% UnchangedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
83 ACUTUS MED INC COM AFIB AFIB 2,660,808 $2.4m0.05% 0.05% AddedShares held: Q3 2022 2.7m, Q4 2022 2.7m, Q1 2023 2.7m, Q2 2023 2.7m +9.1k +9,141 0.3%
84 ELEVATION ONCOLOGY INC COM COM 1,381,416 $2.1m0.04% 0.04% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.4m
85 ANNEXON INC COM ANNX ANNX 583,913 $2.1m0.04% 0.04% UnchangedShares held: Q3 2022 583.9k, Q4 2022 583.9k, Q1 2023 583.9k, Q2 2023 583.9k
86 THE ONCOLOGY INSTITUTE INC COM STLN STLN 3,360,052 $1.8m0.04% 0.04% UnchangedShares held: Q3 2022 3.4m, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
87 ORCHARD THERAPEUTICS PLC SPON ADS NEW SPON ADS NEW 316,169 $1.6m0.04% 0.04% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 316.2k, Q2 2023 316.2k
88 QUANTUM SI INC COM CL A QSI QSI 797,500 $1.4m0.03% 0.03% NewShares held: Q3 2022 1.4m, Q4 2022 0, Q1 2023 0, Q2 2023 797.5k
89 CALCIMEDICA INC COM NEW COM NEW 265,657 $1.1m0.02% 0.02% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 265.7k
90 CAREMAX INC *W EXP 06/08/202 *W EXP 06/08/202 672,000 $259.4k0.01% 0.01% UnchangedShares held: Q3 2022 672.0k, Q4 2022 672.0k, Q1 2023 672.0k, Q2 2023 672.0k
91 MEDAVAIL HOLDINGS INC COM MYOS MYOS 836,626 $205.1k0.00% 0.00% UnchangedShares held: Q3 2022 836.6k, Q4 2022 836.6k, Q1 2023 836.6k, Q2 2023 836.6k
92 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 92,787 $193.9k0.00% 0.00% UnchangedShares held: Q3 2022 0, Q4 2022 92.8k, Q1 2023 92.8k, Q2 2023 92.8k
93 BUTTERFLY NETWORK INC *W EXP 02/12/202 BFLYW BFLYW 733,333 $172.7k0.00% 0.00% UnchangedShares held: Q3 2022 733.3k, Q4 2022 733.3k, Q1 2023 733.3k, Q2 2023 733.3k
94 QUANTUM SI INC *W EXP 06/10/202 *W EXP 06/10/202 333,333 $76.7k0.00% 0.00% UnchangedShares held: Q3 2022 333.3k, Q4 2022 333.3k, Q1 2023 333.3k, Q2 2023 333.3k
95 THE ONCOLOGY INSTITUTE INC *W EXP 11/15/202 STLNW STLNW 1,250,000 $34.9k0.00% 0.00% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
96 SOMALOGIC INC *W EXP 08/31/202 *W EXP 08/31/202 120,000 $30.0k0.00% 0.00% UnchangedShares held: Q3 2022 120.0k, Q4 2022 120.0k, Q1 2023 120.0k, Q2 2023 120.0k
97 SIENTRA INC COM SIEN SIEN 10,000 $29.3k0.00% 0.00% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 10.0k, Q2 2023 10.0k
98 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 166,666 $27.6k0.00% 0.00% UnchangedShares held: Q3 2022 166.7k, Q4 2022 166.7k, Q1 2023 166.7k, Q2 2023 166.7k
99 MEDTECH ACQUISITION CORP *W EXP 12/22/202 *W EXP 12/22/202 333,333 $14.0k0.00% 0.00% UnchangedShares held: Q3 2022 333.3k, Q4 2022 333.3k, Q1 2023 333.3k, Q2 2023 333.3k
100 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 166,666 $9.2k0.00% 0.00% UnchangedShares held: Q3 2022 166.7k, Q4 2022 166.7k, Q1 2023 166.7k, Q2 2023 166.7k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
APELLIS PHARMACEUTICALS INC APLS 3.5 09.15.26 APLS 3.5 09.15.26 51,793,000 $96.0m51.8m shares
PACIRA BIOSCIENCES INC PCRX 0.75 08.01.25 PCRX 0.75 08.01.25 81,600,000 $75.0m81.6m shares
INTERCEPT PHARMACEUTICALS IN ICPT 3.25 07.01.23 ICPT 3.25 07.01.23 57,791,000 $57.0m57.8m shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 2,032,335 $48.8m2.0m shares
INTRA-CELLULAR THERAPIES INC ITCI ITCI 734,000 $39.7m734.0k shares
IVERIC BIO INC OPHT OPHT 1,504,578 $36.6m1.5m shares
EVOLUS INC EOLS EOLS 3,569,000 $30.2m3.6m shares
BELLUS HEALTH INC NEW BLU BLU 3,581,000 $25.8m3.6m shares
KRYSTAL BIOTECH INC KRYS KRYS 311,949 $25.0m311.9k shares
SEMA4 HOLDINGS CORP SMFR SMFR 57,192,101 $20.9m57.2m shares
OAK STR HEALTH INC OSH 0 03.15.26 OSH 0 03.15.26 15,403,000 $15.2m15.4m shares
TARSUS PHARMACEUTICALS INC TARS TARS 1,156,032 $14.5m1.2m shares
INVITAE CORP NVTA NVTA 9,274,707 $12.5m9.3m shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 1,831,607 $11.2m1.8m shares
VAXCYTE INC PCVX PCVX 295,000 $11.1m295.0k shares
VERA THERAPEUTICS INC VERA VERA 1,300,000 $10.1m1.3m shares
PACIFIC BIOSCIENCES CALIF IN PACB PACB 650,000 $7.5m650.0k shares
BLUEBIRD BIO INC 2,175,000 $6.9m2.2m shares
CASTLE BIOSCIENCES INC CSTL CSTL 272,135 $6.2m272.1k shares
RAIN ONCOLOGY INC 227,393 $2.0m227.4k shares
SENIOR CONNECT ACQUISITN COR 500,000 $19.6k500.0k shares
EUCRATES BIOMEDICAL ACQU COR 333,333 $13.5k333.3k shares
EUCRATES BIOMEDICAL ACQU COR 1 $101 shares